Phosphodiesterase 5 inhibitors for the treatment of erectile dysfunction: A trade-off network meta-analysis

European Urology

Volumn 68, Issue 4, 2015, Pages 674-680

  Chen, Liang ^a   Staubli, Sergej E L ^a   Schneider, Marc P ^a,b   Kessels, Alfons G ^c   Ivic, Sandra ^d   Bachmann, Lucas M ^d   Kessler, Thomas M ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b ETH ZURICH   (Switzerland)

^c MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^d MEDIGNITION INC   (Switzerland)

Author keywords

Erectile dysfunction; Network meta analysis; Phosphodiesterase 5 inhibitors

Indexed keywords

AVANAFIL; LODENAFIL; MIRODENAFIL; PHOSPHODIESTERASE V INHIBITOR; PLACEBO; SILDENAFIL; TADALAFIL; UDENAFIL; VARDENAFIL;

CLINICAL PRACTICE; DECISION MAKING; DIABETES MELLITUS; DRUG EFFICACY; DRUG TOLERABILITY; EFFICACY PARAMETERS; ERECTILE DYSFUNCTION; HEALTH CARE; HUMAN; INTERNATIONAL INDEX OF ERECTILE FUNCTION; META ANALYSIS; OPEN STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSTATECTOMY; PUBLICATION; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SYSTEMATIC REVIEW; UNSPECIFIED SIDE EFFECT; CONVALESCENCE; DOSE CALCULATION; DRUG EFFECTS; DRUG SUBSTITUTION; ENZYMOLOGY; MALE; PATHOPHYSIOLOGY; PENIS ERECTION; RISK FACTOR; TREATMENT OUTCOME;

DRUG DOSAGE CALCULATIONS; DRUG SUBSTITUTION; ERECTILE DYSFUNCTION; HUMANS; MALE; PENILE ERECTION; PHOSPHODIESTERASE 5 INHIBITORS; RECOVERY OF FUNCTION; RISK FACTORS; TREATMENT OUTCOME;

EID: 84941802152     PISSN: 03022838     EISSN: 18737560     Source Type: Journal    
DOI: 10.1016/j.eururo.2015.03.031     Document Type: Review

References (18)

1. Hatzimouratidis K, Eardley I, Giuliano F, et al. EAU guidelines on male sexual dysfunction: Erectile dysfunction and premature ejaculation. http://uroweb.org/guideline/male-sexual-dysfunction. 2015.
2. C.B. Johannes, A.B. Araujo, H.A. Feldman, C.A. Derby, K.P. Kleinman, and J.B. McKinlay Incidence of erectile dysfunction in men 40 to 69 years old: longitudinal results from the Massachusetts male aging study J Urol 163 2000 460 463
3. H.A. Feldman, I. Goldstein, D.G. Hatzichristou, R.J. Krane, and J.B. McKinlay Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study J Urol 151 1994 54 61
4. A. Tsertsvadze, H.A. Fink, F. Yazdi, and et al. Oral phosphodiesterase-5 inhibitors and hormonal treatments for erectile dysfunction: a systematic review and meta-analysis Ann Intern Med 151 2009 650 661
5. J. Yuan, R. Zhang, Z. Yang, and et al. Comparative effectiveness and safety of oral phosphodiesterase type 5 inhibitors for erectile dysfunction: a systematic review and network meta-analysis Eur Urol 63 2013 902 912
6. R.A. Moore, S. Derry, and H.J. McQuay Indirect comparison of interventions using published randomised trials: systematic review of PDE-5 inhibitors for erectile dysfunction BMC Urol 5 2005 18
7. N. Buser, S. Ivic, T.M. Kessler, A.G.H. Kessels, and L.M. Bachmann Efficacy and adverse events of antimuscarinics for treating overactive bladder: network meta-analyses Eur Urol 62 2012 1040 1060
8. A.G.H. Kessels, G. ter Riet, M.A. Puhan, J. Kleijnen, L.M. Bachmann, and C.E. Minder A simple regression model for network meta-analysis OA Epidemiology 1 2013 7
9. D. Moher, A. Liberati, J. Tetzlaff, D.G. Altman, and P. Group Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement Ann Intern Med 151 2009 264 269
10. J.C. Cappelleri, R.C. Rosen, M.D. Smith, A. Mishra, and I.H. Osterloh Diagnostic evaluation of the erectile function domain of the International Index of Erectile Function Urology 54 1999 346 351
11. R. Rosen, R. Wood, A. Riley, and G. Wagner Sensitivity and specificity of a questionnaire measure of treatment efficacy in male erectile dysfunction Br J Urol 80 1997 97
12. R.C. Rosen, K.R. Allen, X. Ni, and A.B. Araujo Minimal clinically important differences in the erectile function domain of the International Index of Erectile Function scale Eur Urol 60 2011 1010 1016
13. S.E. Althof, E.W. Corty, S.B. Levine, and et al. EDITS: development of questionnaires for evaluating satisfaction with treatments for erectile dysfunction Urology 53 1999 793 799
14. A.B. Araujo, K.R. Allen, X. Ni, and R.C. Rosen Minimal clinically important differences in the vaginal insertion and successful intercourse items of the sexual encounter profile J Sex Med 9 2012 169 179
15. R.C. Rosen, J.C. Cappelleri, M.D. Smith, J. Lipsky, and B.M. Pena Development and evaluation of an abridged, 5-item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction Int J Impot Res 11 1999 319 326
16. T.M. Kessler, L.M. Bachmann, C. Minder, and et al. Adverse event assessment of antimuscarinics for treating overactive bladder: a network meta-analytic approach PLoS One 6 2011 e16718
17. V. Hasselblad Meta-analysis of multitreatment studies Med Decis Making 18 1998 37 43
18. J.A. Berlin, J. Santanna, C.H. Schmid, L.A. Szczech, and H.I. Feldman Anti-Lymphocyte Antibody Induction Therapy Study Group. Individual patient- versus group-level data meta-regressions for the investigation of treatment effect modifiers: ecological bias rears its ugly head Stat Med 21 2002 371 387